Anti-LEF1 antibody [EPR2029Y]

At abcam, we believe the scientific community goes further, faster, when we go there together. Driven by our passion to help make ground-breaking discoveries and keep research moving, we're constantly innovating by providing products and solutions that play a fundamental role in essential research, drug discovery, and diagnostic and therapeutic applications. We provide tools and scientific support to the research and clinical communities, offering highly validated reagents to address key targets in critical biological pathways. By actively listening to and collaborating with the research community, we continuously advance our portfolio to address their needs. Our principal catalogue product lines include primary and secondary antibodies, conjugated antibodies and conjugation kits, and singleplex immunoassays. We also offer peptides and proteins, knout cell lines and lysates, as well as a variety of other products including cellular activity kits, and biochemical and cell signaling pathway tools. As a pioneer in data sharing and e-commerce, our ambition is to be the most influential company in life sciences for researchers worldwide. Founded in 19998 and headquartered in Cambridge, UK, abcam started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in cancer, neurological disorders, infectious diseases, and metabolic disorder areas.